Joe Vittiglio

Joe Vittiglio has more than two decades of experience advancing the business and legal interests of public and private life sciences companies, with expertise in licensing, collaborations and mergers and acquisitions, financial transactions, FDA regulations, compliance, manufacturing and quality operations for organizations at all stages of development.

He previously served as Chief Business and Legal Officer at Finch Therapeutics, where he guided the company’s initial public offering in 2021, raising $130.8 million in capital, and led the company’s legal, business development and quality teams. Prior to joining Finch in 2020, Joe was the General Counsel and Chief Business Officer for AMAG Pharmaceuticals, where he led the company’s legal and business development initiatives, including oversight of the successful sale of the company to private equity investors, multiple out-licensing and partnership collaborations; and multiple therapeutic product launches. Prior to AMAG, Joe held leadership roles at Flexion Therapeutics, AVEO Pharmaceuticals, and Oscient Pharmaceuticals Corporation. He began his career as a corporate associate at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC where he represented public biotechnology and technology companies in numerous areas, including securities, M&A and healthcare licensing collaborations. He currently serves on the American Cancer Society’s Eastern New England Board of Directors and is on the Board of Advisors for Life Science Cares.

Joe has a BA in international relations from Tufts University and a JD from Northeastern University School of Law.